Philip Morris said it expects to record a loss on the sale of its inhaled-therapeutics unit to Molex Asia Holdings as it retools its pharmaceutical business.
Related Posts
Squarespace Gets Sweetened $7.2 Billion Offer From Permira to Go Private
The new offer price is 5.7% higher than the previous agreement announced in May.
Uber Shares Jump as Company Returns to Profitability
Second-quarter results beat expectations, and the company projected sales growth.
Auto & Transport Roundup: Market Talk
Read about ComfortDelGro, MISC and more in the latest Market Talks covering the Auto and Transport sector.